By Ryan Davis ( May 15, 2019, 7:19 PM EDT) -- The Federal Circuit ruled Wednesday that two patents on Horizon Pharma's pain reliever Vimovo are invalid, backing generics makers and reversing a lower court decision that upheld the patents on a drug that has been in the news for its dramatic price increase....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.